A Case Report of Invasive Klebsiella pneumoniae Liver Abscess Syndrome Treated with Ceftazidime-Avibactam in Combination with Meropenem
Mengying Yang,Baogui Wang
DOI: https://doi.org/10.2147/idr.s480665
2024-09-25
Infection and Drug Resistance
Abstract:Mengying Yang, Baogui Wang Department of Infectious Disease, Fuyang People's Hospital Affiliated to Anhui Medical University, Fuyang, Anhui, 236000, People's Republic of China Correspondence: Baogui Wang, Email Introduction: The emergence of carbapenem-resistant hypervirulent Klebsiella pneumoniae (CR-hvKP) presents a formidable challenge to public health and clinical medicine. This dual phenotype of hypervirulence and multi-drug resistance often complicates treatment options, leaving patients with limited antimicrobial regimens. Consequently, adverse clinical outcomes and high mortality rates are common. Ceftazidime-avibactam (CAZ-AVI) is recognized globally as a critical option for treating infections caused by resistant gram-negative bacteria. Case Report: We present a case of invasive Klebsiella pneumoniae liver abscess syndrome caused by a CR-hvKP infection. The patient exhibited a bloodstream infection, lung and liver abscesses, and suppurative meningitis, eventually developing a brain abscess. Treatment with a combination of meropenem and CAZ-AVI led to a favorable clinical outcome. Conclusion: This case report indicates that combining CAZ-AVI with an antimicrobial agent that is in vitro non-susceptible (carbapenems in this case) is safe and effective for treating severe, multi-site infections caused by CR-hvKP, including central nervous system infections. This case serves as a clinical reference for managing similar patients in practice. Keywords: ceftazidime-avibactam, drug resistance, Klebsiella pneumoniae , next-generation sequencing Carbapenem-resistant hypervirulent Klebsiella pneumoniae (CR-hvKP) infections present a significant challenge for clinicians due to the limited availability of effective therapeutic drugs, often resulting in adverse outcomes and high mortality rates. The Centers for Disease Control and Prevention in the United States have identified CR-hvKP as an urgent threat. 1 China is considered the main endemic region for CR-hvKP, reporting the highest number of cases globally. In this report, we describe a case of invasive Klebsiella pneumoniae liver abscess syndrome caused by a CR-hvKP infection. The patient exhibited a bloodstream infection, liver and lung abscesses, and purulent meningitis, eventually developing a brain abscess. Following treatment with a combination of meropenem and ceftazidime-avibactam (CAZ-AVI), the patient achieved a favorable clinical outcome. A 49-year-old male with a history of diabetes was admitted to the intensive care unit due to abdominal pain and a fever lasting one week, followed by a coma that persisted for 10 hours. Computed tomography (CT) scans revealed infectious lesions in both lungs and a low-density lesion in the right lobe of the liver (Figure 1). Brain magnetic resonance imaging (MRI) showed patchy long T1 and T2 signals in the bilateral basal ganglia, corpus callosum semioval region, genu, and splenium of the corpus callosum, with high signals on diffusion-weighted imaging (Figure 2). Blood tests indicated a white blood cell count of 27.20 x 10 9 /L, procalcitonin of 31.52 ng/mL, and C-reactive protein of 351.00 mg/L. Blood cultures identified sensitive Klebsiella pneumoniae (extended-spectrum β-lactamase-negative). Cerebrospinal fluid (CSF) analysis revealed glucose levels of 5.0 mmol/L, white blood cells of 9457.00 x 10 6 /L, 84% polymorphonuclear cells, and protein levels exceeding 3000.0 mg/L. The CSF bacterial culture was negative. CSF metagenomics next-generation sequencing (mNGS) detected Klebsiella pneumoniae with 6638 sequence reads and virulence genes, including iutA (936 reads), iucA (586 reads), iucD (443 reads), iroB (242 reads), iucC (159 reads), iucB (148 reads), ompA (98 reads), rmpA2 (21 reads), and rmpA (17 reads). Resistance genes identified included SHV-217 (22 reads), indicating resistance to carbapenems, cephalosporins, and penicillins. The liver abscess pus culture was negative. Bronchoalveolar lavage fluid targeted NGS (tNGS) identified Klebsiella pneumoniae with 62,239 sequence reads. The resistance gene detection revealed the presence of the carbapenemase gene blaKPC , and the KPC type of this case is carbapenemase gene - Class A carbapenemase gene. Klebsiella pneumoniae carbapenemases (KPCs) are β-lactamases commonly produced by blaKPC gene-harboring bacteria of the Enterobacteriaceae family, including Klebsiella pneumoniae , Escherichia coli and Enterobacter spp and that are sporadically found in non-fermenting bacteria. 2 This gene encodes a class A serine β-lactamase (class A SBL), which hydrolyzes the β-lactam ring of -Abstract Truncated-
pharmacology & pharmacy,infectious diseases